Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids.
Open Access
- 1 February 1990
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 85 (2), 424-432
- https://doi.org/10.1172/jci114455
Abstract
PGE represent oxygenation products of polyunsaturated essential fatty acids and are important regulators of cell-mediated immune responses. Because oils enriched in such fatty acids reduce inflammation and tissue injury in vivo, we examined the effects of these PGE precursors on IL-2-driven growth of human T lymphocytes. Dihomogamma linoleic acid (DGLA), AA, and their metabolites (PGE1 and PGE2, respectively) strongly inhibited short- and long-term growth of IL-2-dependent T cell cultures; EPA was much less inhibitory and its product, PGE3, failed to suppress IL-2 responses. Short-term pretreatment of the cells with DGLA or AA and removal of the fatty acids before the proliferation assay resulted in a smaller reduction in [3H]TdR incorporation. PGE and fatty acids did not alter the number of high affinity IL-2 binding sites on the T cell cultures but reduced the percentage of cells expressing CD25 and HLA class II molecules. No PGE was detected in supernatants from the fatty acid-treated cultures. Moreover, indomethacin, a cyclooxygenase inhibitor, did not reverse the antiproliferative effects of the fatty acids. Together, these findings indicate that fatty acids can inhibit IL-2-driven T cell growth via a PGE-independent mechanism and might be relevant to inflammatory diseases associated with persistent T cell activation.Keywords
This publication has 72 references indexed in Scilit:
- The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear CellsNew England Journal of Medicine, 1989
- Soluble interleukin‐2 receptors in systemic lupus erythematosusArthritis & Rheumatism, 1988
- The interleukin 2 receptor. Functional consequences of its bimolecular structure.The Journal of Experimental Medicine, 1987
- Insulin‐like growth factor‐I: Specific binding to high and low affinity sites and mitogenic action throughout the life span of WI‐38 cellsJournal of Cellular Physiology, 1987
- Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate.JCI Insight, 1987
- The combined effect of prostaglandin E2 and interleukin 1 on interleukin 2 production and lymphocyte proliferationInternational Journal of Immunopharmacology, 1987
- Glucose-induced phospholipid hydrolysis in isolated pancreatic islets: quantitative effects on the phospholipid content of arachidonate and other fatty acidsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex.The Journal of Experimental Medicine, 1985
- Suppression of B-cell and T-cell responses by the prostaglandin-induced T-cell-derived suppressor (PITS): II. Resolution of multiple PITSβ factorsCellular Immunology, 1984
- Prostaglandin E Modulation of the Mitogenic Response of Human T CellsJCI Insight, 1979